3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Phase 1/2
1
Status
Terminated
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Conditions
Tumor Lysis Syndrome
1
Hematologic Neoplasms
1
Interventions
rasburicase
1
alvocidib
1
Febuxostat
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1/2
×
Tumor Lysis Syndrome
×
Febuxostat
×
Clear all
NCT03605212
2021-06-03
FLORET
Menarini Group
Phase 1/2
Terminated
30 enrolled
14 charts